NO884835D0 - PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE TETRAHYDRO-FURO- AND TIENO (2,3.-C) PYRIDINES. - Google Patents
PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE TETRAHYDRO-FURO- AND TIENO (2,3.-C) PYRIDINES.Info
- Publication number
- NO884835D0 NO884835D0 NO884835A NO884835A NO884835D0 NO 884835 D0 NO884835 D0 NO 884835D0 NO 884835 A NO884835 A NO 884835A NO 884835 A NO884835 A NO 884835A NO 884835 D0 NO884835 D0 NO 884835D0
- Authority
- NO
- Norway
- Prior art keywords
- tieno
- furo
- pyridines
- procedure
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Ophthalmology & Optometry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19873736664 DE3736664A1 (en) | 1987-10-29 | 1987-10-29 | TETRAHYDRO-FURO- AND -THIENO (2,3-C) PYRIDINE, THEIR USE AS A MEDICAMENT AND METHOD FOR THE PRODUCTION THEREOF |
Publications (2)
Publication Number | Publication Date |
---|---|
NO884835D0 true NO884835D0 (en) | 1988-10-28 |
NO884835L NO884835L (en) | 1989-05-02 |
Family
ID=6339349
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO88884835A NO884835L (en) | 1987-10-29 | 1988-10-28 | PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE TETRAHYDRO-FURO-AND-TIENO (2,3.-C) PYRIDINES. |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP0314154A3 (en) |
JP (1) | JPH01157983A (en) |
KR (1) | KR890006650A (en) |
AU (1) | AU2443588A (en) |
CS (1) | CS273193B2 (en) |
DD (1) | DD283395A5 (en) |
DE (1) | DE3736664A1 (en) |
DK (1) | DK603588A (en) |
FI (1) | FI884947A (en) |
HU (1) | HU201553B (en) |
IL (1) | IL88184A0 (en) |
NO (1) | NO884835L (en) |
PL (1) | PL275555A1 (en) |
PT (1) | PT88899B (en) |
SU (1) | SU1657064A3 (en) |
YU (1) | YU201288A (en) |
ZA (1) | ZA888089B (en) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2623810B2 (en) * | 1987-02-17 | 1992-01-24 | Sanofi Sa | ALPHA SALTS- (TETRAHYDRO-4,5,6,7 THIENO (3,2-C) PYRIDYL-5) (2-CHLORO-PHENYL) -THETHYL ACETATE DEXTROGYRE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME |
US5272148A (en) * | 1992-09-09 | 1993-12-21 | Hoechst-Roussel Pharmaceuticals Incorporated | Heteroarenylpiperazines |
US8914114B2 (en) | 2000-05-23 | 2014-12-16 | The Feinstein Institute For Medical Research | Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation |
CA2476896A1 (en) * | 2002-02-26 | 2003-09-04 | North Shore-Long Island Jewish Research Institute | Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors |
EP1734941A2 (en) | 2004-03-25 | 2006-12-27 | The Feinstein Institute for Medical Research | Neural tourniquet |
US10912712B2 (en) | 2004-03-25 | 2021-02-09 | The Feinstein Institutes For Medical Research | Treatment of bleeding by non-invasive stimulation |
US11207518B2 (en) | 2004-12-27 | 2021-12-28 | The Feinstein Institutes For Medical Research | Treating inflammatory disorders by stimulation of the cholinergic anti-inflammatory pathway |
EP1833559B1 (en) | 2004-12-27 | 2010-11-24 | The Feinstein Institute for Medical Research | Treating inflammatory disorders by electrical vagus nerve stimulation |
US8391970B2 (en) | 2007-08-27 | 2013-03-05 | The Feinstein Institute For Medical Research | Devices and methods for inhibiting granulocyte activation by neural stimulation |
US9662490B2 (en) | 2008-03-31 | 2017-05-30 | The Feinstein Institute For Medical Research | Methods and systems for reducing inflammation by neuromodulation and administration of an anti-inflammatory drug |
US9211409B2 (en) | 2008-03-31 | 2015-12-15 | The Feinstein Institute For Medical Research | Methods and systems for reducing inflammation by neuromodulation of T-cell activity |
CN102215909B (en) | 2008-11-18 | 2014-09-10 | 赛博恩特医疗器械公司 | Devices and methods for optimizing electrode placement for anti-inflamatory stimulation |
US9211410B2 (en) | 2009-05-01 | 2015-12-15 | Setpoint Medical Corporation | Extremely low duty-cycle activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation |
US8612002B2 (en) | 2009-12-23 | 2013-12-17 | Setpoint Medical Corporation | Neural stimulation devices and systems for treatment of chronic inflammation |
US8996116B2 (en) | 2009-10-30 | 2015-03-31 | Setpoint Medical Corporation | Modulation of the cholinergic anti-inflammatory pathway to treat pain or addiction |
CN102573986B (en) | 2009-06-09 | 2016-01-20 | 赛博恩特医疗器械公司 | For the nerve cuff with bag portion without wire stimulator |
US9833621B2 (en) | 2011-09-23 | 2017-12-05 | Setpoint Medical Corporation | Modulation of sirtuins by vagus nerve stimulation |
US11051744B2 (en) | 2009-11-17 | 2021-07-06 | Setpoint Medical Corporation | Closed-loop vagus nerve stimulation |
US12172017B2 (en) | 2011-05-09 | 2024-12-24 | Setpoint Medical Corporation | Vagus nerve stimulation to treat neurodegenerative disorders |
WO2012154865A2 (en) | 2011-05-09 | 2012-11-15 | Setpoint Medical Corporation | Single-pulse activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation |
US9572983B2 (en) | 2012-03-26 | 2017-02-21 | Setpoint Medical Corporation | Devices and methods for modulation of bone erosion |
US11311725B2 (en) | 2014-10-24 | 2022-04-26 | Setpoint Medical Corporation | Systems and methods for stimulating and/or monitoring loci in the brain to treat inflammation and to enhance vagus nerve stimulation |
WO2016126807A1 (en) | 2015-02-03 | 2016-08-11 | Setpoint Medical Corporation | Apparatus and method for reminding, prompting, or alerting a patient with an implanted stimulator |
US10596367B2 (en) | 2016-01-13 | 2020-03-24 | Setpoint Medical Corporation | Systems and methods for establishing a nerve block |
US11471681B2 (en) | 2016-01-20 | 2022-10-18 | Setpoint Medical Corporation | Batteryless implantable microstimulators |
US10695569B2 (en) | 2016-01-20 | 2020-06-30 | Setpoint Medical Corporation | Control of vagal stimulation |
WO2017127758A1 (en) | 2016-01-20 | 2017-07-27 | Setpoint Medical Corporation | Implantable microstimulators and inductive charging systems |
US10583304B2 (en) | 2016-01-25 | 2020-03-10 | Setpoint Medical Corporation | Implantable neurostimulator having power control and thermal regulation and methods of use |
US11173307B2 (en) | 2017-08-14 | 2021-11-16 | Setpoint Medical Corporation | Vagus nerve stimulation pre-screening test |
US11260229B2 (en) | 2018-09-25 | 2022-03-01 | The Feinstein Institutes For Medical Research | Methods and apparatuses for reducing bleeding via coordinated trigeminal and vagal nerve stimulation |
KR20230012585A (en) | 2020-05-21 | 2023-01-26 | 더 파인스타인 인스티튜츠 포 메디칼 리서치 | Systems and methods for vagus nerve stimulation |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2315274A1 (en) * | 1975-06-27 | 1977-01-21 | Parcor | NEW DERIVATIVES OF THIENO (2,3-C) PYRIDINE, THEIR PREPARATION AND THEIR APPLICATIONS |
FR2317303A1 (en) * | 1975-07-09 | 1977-02-04 | Parcor | PROCESS FOR PREPARING TETRAHYDROTHIENO (3,2-C) AND (2,3-C) PYRIDINE DERIVATIVES |
-
1987
- 1987-10-29 DE DE19873736664 patent/DE3736664A1/en not_active Withdrawn
-
1988
- 1988-10-27 FI FI884947A patent/FI884947A/en not_active IP Right Cessation
- 1988-10-27 YU YU02012/88A patent/YU201288A/en unknown
- 1988-10-27 DD DD88321141A patent/DD283395A5/en not_active IP Right Cessation
- 1988-10-27 CS CS712688A patent/CS273193B2/en unknown
- 1988-10-27 IL IL88184A patent/IL88184A0/en unknown
- 1988-10-28 PL PL27555588A patent/PL275555A1/en unknown
- 1988-10-28 JP JP63272853A patent/JPH01157983A/en active Pending
- 1988-10-28 PT PT88899A patent/PT88899B/en not_active IP Right Cessation
- 1988-10-28 EP EP19880117961 patent/EP0314154A3/en not_active Withdrawn
- 1988-10-28 ZA ZA888089A patent/ZA888089B/en unknown
- 1988-10-28 DK DK603588A patent/DK603588A/en not_active Application Discontinuation
- 1988-10-28 AU AU24435/88A patent/AU2443588A/en not_active Abandoned
- 1988-10-28 HU HU885642A patent/HU201553B/en not_active IP Right Cessation
- 1988-10-28 NO NO88884835A patent/NO884835L/en unknown
- 1988-10-28 KR KR1019880014063A patent/KR890006650A/en not_active Application Discontinuation
- 1988-10-28 SU SU884356747A patent/SU1657064A3/en active
Also Published As
Publication number | Publication date |
---|---|
AU2443588A (en) | 1989-07-13 |
EP0314154A3 (en) | 1990-12-05 |
HUT50824A (en) | 1990-03-28 |
CS712688A2 (en) | 1990-06-13 |
JPH01157983A (en) | 1989-06-21 |
NO884835L (en) | 1989-05-02 |
ZA888089B (en) | 1990-07-25 |
HU201553B (en) | 1990-11-28 |
PL275555A1 (en) | 1989-05-02 |
CS273193B2 (en) | 1991-03-12 |
DK603588D0 (en) | 1988-10-28 |
PT88899B (en) | 1993-01-29 |
DD283395A5 (en) | 1990-10-10 |
YU201288A (en) | 1990-08-31 |
DE3736664A1 (en) | 1989-05-11 |
FI884947A0 (en) | 1988-10-27 |
SU1657064A3 (en) | 1991-06-15 |
DK603588A (en) | 1989-04-30 |
IL88184A0 (en) | 1989-06-30 |
FI884947A (en) | 1989-04-30 |
EP0314154A2 (en) | 1989-05-03 |
KR890006650A (en) | 1989-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO884835D0 (en) | PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE TETRAHYDRO-FURO- AND TIENO (2,3.-C) PYRIDINES. | |
NO884154D0 (en) | PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PREPARATIONS. | |
NO883974D0 (en) | PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE TETRAHYDRO-HYDROXYPYRANON DERIVATIVES. | |
NO880182L (en) | PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 1,2-DIHYDRO-3H-INDAZOL-3-ON DERIVATIVES. | |
NO166367C (en) | ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE TIENO-1,4-DIAZEPINES. | |
NO166281C (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE 1,1-DISUBSTITUTED CYCLOPROPANDER DERIVATIVES. | |
NO163619C (en) | ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE TETRAHYDRO-2-HETEROCYCLOYLKYLPYRIDO (4,3) INDOLES. | |
NO169963C (en) | ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE, SUBSTITUTED 3,4-DIHYDRO-2H-BENZOPYRANES | |
FI871087A0 (en) | Process for the preparation of therapeutically active 1,2,3,4-tetrahydro-3-carbamoyl-2-thioxo / oxo-5-pyrimidinecarboxylic acid derivatives | |
NO166326C (en) | PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 3,7-SUBSTITUTED-8-OXO-5-THIA-1-AZABICYCLO- (4,2,0) OCT-2-EN-2-CARBOXYLATER. | |
NO167668C (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE EPIPODOPHYLLOTOXING LUCOSIDE-4'-ACYL DERIVATIVES. | |
NO881768L (en) | PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 1,3-DIOXANES. | |
NO862390D0 (en) | PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 1,4-DIHYDROPYRIDINE DERIVATIVES. | |
NO165542C (en) | ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 5-ARYL-2,4-DIALKYL-3H-1,2,4-TRIAZOL-3-THIONER. | |
NO854277L (en) | PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 6-PHENETYLAMINOALKYL-7-HYDROXY-FURO- (3,4-C) -PYRIDINE DERIVATIVES. | |
NO865148D0 (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE, SUBSTITUTED BENZAMIDES. | |
NO166642C (en) | ANAOLOGICAL PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 3-ARYL-5-ALKYLTHIO-4H-1,2,4-TRIAZOLES. | |
NO163777C (en) | ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE DIOXINO (4,5-C) -PYRIDINE DERIVATIVES. | |
NO882281D0 (en) | PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PYRAZINAMIDES. | |
NO880409D0 (en) | PROCEDURE FOR THE PREPARATION OF 14.15 SUBSTITUTED LANOSTEROLS. | |
NO164973C (en) | ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE GEM-DIHALO- AND TETRAHALO-1,2-DIAMINO-4,9, -DIAZA-DODECANES. | |
NO852563L (en) | PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PYRIDINE DERIVATIVES. | |
NO883959L (en) | PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PHENOLESTERS. | |
NO882282L (en) | PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PYRAZINAMIDES. | |
NO882201D0 (en) | PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PYRIDINE DERIVATIVES. |